Regulations.gov document
Non-Penicillin Beta-Lactam Drugs: A CGMP Framework for Preventing Cross-Contamination…
Notice · FDA-2011-D-0104 · posted Jun 24, 2022
Key facts
| Document ID | FDA-2011-D-0104-0018 |
|---|---|
| Title | Non-Penicillin Beta-Lactam Drugs: A CGMP Framework for Preventing Cross-Contamination; Draft Guidance for Industry; Availability |
| Document type | Notice |
| Subtype | Notice of Availability |
| Agency | FDA |
| Docket | FDA-2011-D-0104 |
| Posted | Jun 24, 2022 |
| Federal Register citation | 87 FR 37870 |
| FR document number | 2022-13513 |
| Comment period opens | Jun 24, 2022 |
| Effective date | Jun 24, 2022 |
At a glance
- 1–9 Pages
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: